APA (7th ed.) Citation

Li, J., Di, G., Tang, L., Yu, K., Hu, Z., Liu, G., . . . Shao, Z. (2011). Adjuvant Therapy of Breast Cancer with Pirarubicin Versus Epirubicin in Combination with Cyclophosphamide and 5-fluorouracil. Breast Journal, 17(6), 657. https://doi.org/10.1111/j.1524-4741.2011.01158.x

Chicago Style (17th ed.) Citation

Li, Jun-Jie, et al. "Adjuvant Therapy of Breast Cancer with Pirarubicin Versus Epirubicin in Combination with Cyclophosphamide and 5-fluorouracil." Breast Journal 17, no. 6 (2011): 657. https://doi.org/10.1111/j.1524-4741.2011.01158.x.

MLA (9th ed.) Citation

Li, Jun-Jie, et al. "Adjuvant Therapy of Breast Cancer with Pirarubicin Versus Epirubicin in Combination with Cyclophosphamide and 5-fluorouracil." Breast Journal, vol. 17, no. 6, 2011, p. 657, https://doi.org/10.1111/j.1524-4741.2011.01158.x.